Literature DB >> 7815961

Molecular interactions between G-actin, DNase I and the beta-thymosins in apoptosis: a hypothesis.

A K Hall1.   

Abstract

The beta-thymosins are a family of < 5kDa (MW), mostly acidic, proteins which were originally defined in the immune system. Recently, specific members of this family of cytoplasmic polypeptides, namely beta-4 and beta-10, were shown to bind monomeric G-actin both in vitro and in vivo. Whilst many aspects of programmed cell death or 'apoptosis' remain to be defined, the Ca2+/Mg(2+)-dependent endonuclease, DNase I does feature in this process. Monomeric G-actin binds to and inhibits the DNA-degrading activity of DNase I. Given that the intracellular abundance of thymosins beta-4 and beta-10 is related to cell division and differentiation and that anticancer/morphogenic agents such as retinoic acid (RA) and cyclic AMP modulate expression of their respective genes, it is possible that these G-actin sequestering proteins play significant roles in apoptosis perhaps mediated via DNase I.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7815961     DOI: 10.1016/0306-9877(94)90135-x

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  3 in total

1.  Expression patterns of Thymosin β4 and cancer stem cell marker CD133 in ovarian cancers.

Authors:  Yong-Il Ji; Bo-Young Lee; Yun-Jeong Kang; Jin-Ok Jo; Sang Ho Lee; Heung Yeol Kim; Young-Ok Kim; Chulmin Lee; Suk Bong Koh; Ari Kim; Ji Young Lee; Min Hyung Jung; Mee Sun Ock; Hee-Jae Cha
Journal:  Pathol Oncol Res       Date:  2012-10-10       Impact factor: 3.201

2.  Thymosin-beta4 regulates motility and metastasis of malignant mouse fibrosarcoma cells.

Authors:  Tokushige Kobayashi; Futoshi Okada; Nobuyuki Fujii; Naoko Tomita; Satoru Ito; Hiroshi Tazawa; Tetsuya Aoyama; Sung Ki Choi; Toshiyuki Shibata; Hisakazu Fujita; Masuo Hosokawa
Journal:  Am J Pathol       Date:  2002-03       Impact factor: 4.307

3.  DNase I aggravates islet β-cell apoptosis in type 2 diabetes.

Authors:  Bin Zhu; Lei Zhang; Yue-Ying Zhang; Lei Wang; Xin-Gang Li; Teng Liu; Yu-Ke Fu; Yan-Fei Zheng; Ping Li; Zhi-Gang Zhao
Journal:  Mol Med Rep       Date:  2016-04-11       Impact factor: 2.952

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.